Inventor
LAINCHBURY MICHAEL
GB16 patents
⚠️ This page may combine multiple inventors who share the name “LAINCHBURY MICHAEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GENENTECH INC
10 patentsUS9890152B2Feb 13, 2018
Aminopyrimidine compounds as inhibitors of T790M containing EGFR mutants
GENENTECH INC7 citations82
US11566003B2Jan 31, 2023
Isoquinolines as inhibitors of HPK1
GENENTECH INC4 citations72
US10407424B2Sep 10, 2019
Naphthyridines as inhibitors of HPK1
GENENTECH INC5 citations71
US9951064B2Apr 24, 2018
Azaindazole compounds as inhibitors of T790M containing EGFR mutants
GENENTECH INC5 citations71
US11944606B2Apr 2, 2024
Azaindoles as inhibitors of HPK1
GENENTECH INC0 citations61
US10952995B2Mar 23, 2021
Azaindoles as inhibitors of HPK1
GENENTECH INC0 citations61
US11034692B1Jun 15, 2021
Naphthyridines as inhibitors of HPK1
GENENTECH INC1 citations60
US12297210B2May 13, 2025
Naphthyridine compounds and uses thereof
GENENTECH INC0 citations50
US12208088B2Jan 28, 2025
Spirocyclic 2,3-dihydro-7-azaindole compounds and uses thereof
GENENTECH INC0 citations50
US12378249B2Aug 5, 2025
Isoquinoline compounds and uses thereof
GENENTECH INC0 citations49
CANCER RES TECH LTD
3 patentsUS9765059B2Sep 19, 2017
5-(Pyridin-2-yl-amino)-pyrazine-2-carbonitrile compounds and their therapeutic use
CANCER RES TECH LTD6 citations83
US9403797B2Aug 2, 2016
5-(pyridin-2-yl-amino)-pyrazine-2-carbonitrile compounds and their therapeutic use
CANCER RES TECH LTD6 citations83
US9663503B2May 30, 2017
5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2-pyridyl]amino]pyrazine-2-carbonitrile and therapeutic uses thereof
CANCER RES TECH LTD5 citations81
CANCER RESEARCH TECH LTD
2 patentsUS11787792B2Oct 17, 2023
5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2 Pyridyl]Amino]Pyrazine-2-carbonitrile and therapeutic uses thereof
CANCER RESEARCH TECH LTD1 citations70
US10259806B2Apr 16, 2019
5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2 pyridyl]amino]pyrazine-2-carbonitrile and therapeutic uses thereof
CANCER RESEARCH TECH LTD2 citations70